Bristol-Myers Squibb

Expecting A Buy Bristol Myers Squibb Takeover? You Might Be Waiting A While
Barron's
Fri, 04/21/17 - 11:49 am
Bristol-Myers Squibb
M&A
earnings
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Fierce Pharma
Wed, 04/19/17 - 04:21 pm
earnings
drug pricing
Bristol-Myers Squibb
AbbVie
Roche
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Endpoints
Wed, 04/19/17 - 04:17 pm
Bristol-Myers Squibb
cancer
vaccines
Bavarian Nordic
Prostvac
Opdivo
Yervoy
Biogen Snaps Up A 'Rare Find' From BMS: Instinet
Barron's
Sat, 04/15/17 - 09:25 am
Biogen
Bristol-Myers Squibb
BMS-986168
progressive supranuclear palsy
Bristol-Myers to license two drugs to Biogen, Roche
Yahoo/Reuters
Thu, 04/13/17 - 11:52 am
Bristol-Myers Squibb
Biogen
Roche
BMS-986168
BMS-986089
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
Fierce Pharma
Thu, 04/13/17 - 11:51 am
Bristol-Myers Squibb
Pfizer
patents
Eliquis
patent lawsuits
generics
bloodthinners
Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M
Fierce Pharma
Thu, 04/13/17 - 11:50 am
Opdivo
Bristol-Myers Squibb
executive pay
Giovanni Caforio
Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer
Fierce Pharma
Wed, 04/12/17 - 06:07 pm
Bristol-Myers Squibb
Opdivo
NICE
head and neck cancer
3 Big Drugmakers Most Likely to Buy Incyte
Motley Fool
Wed, 04/12/17 - 11:57 am
Incyte
M&A
Gilead Sciences
Amgen
Bristol-Myers Squibb
Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials
Fierce Pharma
Tue, 04/4/17 - 11:10 pm
Merck
Bristol-Myers Squibb
Incyte
Keytruda
Opdivo
non-small cell lung cancer
Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Marketwatch
Tue, 04/4/17 - 11:01 pm
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Endpoints
Tue, 04/4/17 - 07:35 pm
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
For Bristol-Myers, A Victory And A Mystery
Forbes
Mon, 04/3/17 - 11:44 am
Bristol-Myers Squibb
Opdivo
melanoma
The cost of cancer: new drugs show success at a steep price
Yahoo/Reuters
Mon, 04/3/17 - 09:13 am
cancer
Bristol-Myers Squibb
Merck
Roche
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
Fierce Pharma
Sat, 04/1/17 - 08:14 am
JNJ
Pfizer
Merck
AbbVie
Eli Lilly
Bristol-Myers Squibb
Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents
Yahoo
Thu, 03/30/17 - 09:35 am
Bristol-Myers Squibb
Foundation Medicine
R&D
tumors
immunology
Pfizer Up on Bristol-Myers Takeover Talk
Investopedia
Mon, 03/27/17 - 11:43 pm
Pfizer
Bristol-Myers Squibb
M&A
Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?
Barron's
Mon, 03/27/17 - 11:41 pm
Bristol-Myers Squibb
Pfizer
M&A
7 Pharma Plays With Emerging Market Potential
Barron's
Wed, 03/22/17 - 10:59 pm
emerging markets
Pfizer
GSK
Sanofi
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Dr Reddy's
Struggling Heat gets a warm response to a snapshot on cancer vax data
Endpoints
Tue, 03/21/17 - 10:06 am
Heat Biologics
vaccines
HS-110
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo

Pages